Dulaglutide vs Exenatide
Molecule comparison
Last updated 2026-05-28 15:46 UTCDulaglutide (brand name Trulicity) and Exenatide (brand names Byetta and Bydureon) are both GLP-1 receptor agonists, a type of medication that helps control blood sugar. Dulaglutide is FDA-approved to treat type 2 diabetes and reduce cardiovascular risk, while Exenatide is approved only for type 2 diabetes. Dulaglutide is given as a once-weekly injection, whereas Exenatide comes in two forms: a twice-daily injection (Byetta) and a once-weekly injection (Bydureon).
AI summary of the sources below.
| Dulaglutide | Exenatide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Status | Approved | Approved |
| Branded products | trulicity | byetta, bydureon |
Compare full details on the Dulaglutide and Exenatide pages.